Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31442 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Waiel Abusnina und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Adenosine Monophosphate, Healthcare Disparities, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Cangrelor is an intravenous P2Y12 receptor antagonist that exerts rapid and potent antiplatelet effects. It is associated with a reduction in the indcidence of ischemic events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
Aims
The aim of our study was to investigate the racial disparities and their impact on outcomes among patients with ACS who were treated with cangrelor during PCI.
Methods
We reviewed the data of patients with ACS who were treated with cangrelor during PCI at our center from 2018 to 2023 and divided between African American (AA) and Caucasian patients. The primary safety outcome was in‐hospital thrombolysis in myocardial infarction (TIMI) major bleeding. The primary efficacy outcome was in‐hospital major adverse cardiac events (MACE), defined as a composite of cardiac death, MI, or stroke. Multivariate regression analysis was performed to assess the primary outcomes after controlling for differences in baseline characteristics.
Results
The study included 1181 patients who received cangrelor during PCI for ACS, including 616 AA and 565 Caucasian patients. AA patients were significantly younger (61 ± 13 vs. 64 ± 12 years; p < 0.001) and had higher rates of hypertension, diabetes mellitus, and end‐stage renal disease requiring dialysis. There were no significant differences between AA and Caucasian patients regarding in‐hospital TIMI major bleeding (odds ratio [OR]: 0.55; 95% confidence interval [CI]: 0.16–1.88 ; p = 0.343) and in‐hospital MACE (OR: 1.82; 95% CI: 0.71–4.69 ; p = 0.212) after controlling for relevant baseline differences.
Conclusion
No racial disparities were observed with regard to the administration of cangrelor during PCI in patients presenting with ACS, and cangrelor was not associated with increased bleeding for AA patients as compared to Caucasian patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
ORCID-Profile: Kalyan R Chitturi, Ron Waksman
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Abusnina, W., Chitturi, K. R., Chaturvedi, A., Lupu, L., Haberman, D., Cellamare, M., Sawant, V., Zhang, C., Ben-Dor, I., Satler, L. F., Hashim, H. D., Case, B. C., & Waksman, R. (2025). Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31442
Vancouver
Abusnina W, Chitturi KR, Chaturvedi A, Lupu L, Haberman D, Cellamare M, et al. Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31442
BibTeX
@article{Abusnina2025,
author = {Abusnina, Waiel and Chitturi, Kalyan R and Chaturvedi, Abhishek and Lupu, Lior and Haberman, Dan and Cellamare, Matteo and Sawant, Vaishnavi and Zhang, Cheng and Ben-Dor, Itsik and Satler, Lowell F and Hashim, Hayder D and Case, Brian C and Waksman, Ron},
title = {Lack of Racial Disparities in Cangrelor Therapy in Patients Presenting With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31442}
}
EUVIMED